Scarica l'app Stockscreener
15.00
0.53%
-0.08
Precedente Chiudi:
$15.08
Aprire:
$15.26
Volume 24 ore:
290.88K
Relative Volume:
0.64
Capitalizzazione di mercato:
$5.35B
Reddito:
$5.21B
Utile/perdita netta:
$-211.00M
Rapporto P/E:
-24.28
EPS:
-0.6179
Flusso di cassa netto:
$861.30K
1 W Prestazione:
-1.19%
1M Prestazione:
-6.77%
6M Prestazione:
-12.23%
1 anno Prestazione:
+21.65%
Intervallo 1D:
$14.89
$15.39
Intervallo di 1 settimana:
$14.89
$15.77
Portata 52W:
$11.44
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Nome
Bausch Lomb Corp
Settore
Industria
Telefono
908-541-5456
Indirizzo
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.00 | 5.35B | 5.21B | -211.00M | 861.30K | -0.6179 |
ISRG
Intuitive Surgical Inc
|
416.55 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.52 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.29 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.33 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
192.74 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | Iniziato | Goldman | Neutral |
| 2025-05-02 | Reiterato | H.C. Wainwright | Buy |
| 2025-03-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Iniziato | Raymond James | Outperform |
| 2024-05-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Iniziato | Stifel | Hold |
| 2023-10-03 | Ripresa | Evercore ISI | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Iniziato | Needham | Hold |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-12 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-06-24 | Iniziato | Evercore ISI | Outperform |
| 2022-06-06 | Iniziato | Citigroup | Buy |
| 2022-05-31 | Iniziato | Deutsche Bank | Hold |
| 2022-05-31 | Iniziato | Goldman | Neutral |
| 2022-05-31 | Iniziato | Guggenheim | Buy |
| 2022-05-31 | Iniziato | JP Morgan | Neutral |
| 2022-05-31 | Iniziato | Jefferies | Buy |
| 2022-05-31 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Iniziato | Wells Fargo | Overweight |
| 2022-05-11 | Iniziato | Cowen | Outperform |
Mostra tutto
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Bausch + Lomb to lay off employees in Missouri - Yahoo Finance
Transcript : Bausch + Lomb Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 01 - marketscreener.com
Bausch + Lomb Dry Eye Launch Highlights Valuation Gap And Growth Questions - Yahoo Finance
Why Bausch + Lomb Corp stock is sliding today - Wealth Awesome
Bausch + Lomb Corporation (BLCO): Investor Outlook and Potential 15.62% Upside in the Healthcare Sector - DirectorsTalk Interviews
Will Blink Triple Care’s Preservative Free Launch Reshape Bausch + Lomb’s (BLCO) Consumer Eye Care Narrative? - webull.com
Bausch + Lomb’s New Dry Eye Launch And What It Means For BLCO - Sahm
RBC Capital reiterates Bausch & Lomb stock rating at Outperform By Investing.com - Investing.com Australia
RBC Capital reiterates Bausch & Lomb stock rating at Outperform - Investing.com
Bausch + Lomb Corp stock (CA07174N1090): valuation metrics in focus after recent trading in Toronto - AD HOC NEWS
Liquidity Mapping Around (BLCO) Price Events - Stock Traders Daily
Bausch + Lomb Corp. Price Target Is Maintained at $19.00/Share by Citi - Moomoo
BLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States - BioSpace
Preservative-free eye drops offer up to 10 hours dry-eye relief - Stock Titan
Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Growth Potential with a 14% Upside - DirectorsTalk Interviews
BLCO Stock Price, Quote & Chart | BAUSCH + LOMB CORP (NYSE:BLCO) - ChartMill
Bausch & Lomb (BLCO) director awarded 15,842 RSUs under 2022 Omnibus Incentive Plan - Stock Titan
Bausch & Lomb (NYSE: BLCO) grants 15,842 RSUs to director - Stock Titan
Bausch & Lomb (NYSE: BLCO) director awarded 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director John Paulson receives 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director Karen Ling awarded 15,842 RSUs as annual equity grant - Stock Titan
Director at Bausch & Lomb (NYSE: BLCO) gets 15,842-share RSU award - Stock Titan
Bausch & Lomb Corp (BLCO) awards 15,842 RSUs to director Collis - Stock Titan
Bausch & Lomb (BLCO) director granted 15,842 RSUs in annual equity award - Stock Titan
Bausch & Lomb (NYSE: BLCO) director receives 15,842-share RSU grant - Stock Titan
Bausch + Lomb Lifts 2026 Guidance, 1Q Loss Narrows - Moomoo
Bausch & Lomb (NYSE: BLCO) CEO reports 2,886-share tax withholding on RSU vesting - Stock Titan
Bausch + Lomb: Even Though Growth Continues, I Don't See A Way Higher (NYSE:BLCO) - Seeking Alpha
Evercore ISI Group Maintains Bausch + Lomb (BLCO) Outperform Recommendation - MSN
Bausch + Lomb Corporation (BLCO) Stock Analysis: Unpacking a Potential 13% Upside for Investors - DirectorsTalk Interviews
Brent Saunders: Healthcare Innovation Leader, Global Pharmaceutical Executive, and Bausch + Lomb CEO - BBN Times
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Medical Devices & SuppliesSpecialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest - Yahoo Finance
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb CEO, R&D chief to join Goldman Sachs health-care chat - Stock Titan
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results - BioSpace
Board re-elected, exec pay backed: inside Bausch + Lomb’s 2026 vote - Stock Titan
Bausch + Lomb (BLCO) investors approve board, pay and PwC auditor at 2026 meeting - Stock Titan
Bausch + Lomb unveils PreserVision AREDS3 eye vitamins in the U.S. - Mass Market Retailers
New eye vitamin targets leading cause of vision loss in older Americans - Stock Titan
Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring the 12% Upside Potential in Eye Health - DirectorsTalk Interviews
How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA Momentum - Yahoo Finance
Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This Stock - Insider Monkey
Bausch + Lomb launches advanced dual-port vitrectomy cutter in Europe - Ophthalmology Times Europe
BLCO (BLCO) CFO has 63,938 shares withheld to cover RSU taxes - Stock Titan
Tax withholding trims Bausch & Lomb (NYSE: BLCO) EVP share count - Stock Titan
Bausch & Lomb (NYSE: BLCO) SVP has 8,673 shares withheld for RSU taxes - Stock Titan
Bausch & Lomb (BLCO) executive reports 11,970-share RSU tax withholding on Form 4 - Stock Titan
Bausch Lomb Corp Azioni (BLCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
1.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):